Colgate-Palmolive (NYSE:CL) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Colgate-Palmolive (NYSE:CL) have earned a consensus rating of “Moderate Buy” from the twenty-two research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have assigned a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $104.74.

Several brokerages have recently issued reports on CL. Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price target for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Barclays raised their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research note on Monday, July 29th. BNP Paribas started coverage on shares of Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 price objective for the company. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 target price on the stock. Finally, Jefferies Financial Group downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price target for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th.

Insiders Place Their Bets

In related news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock worth $4,486,063 in the last three months. 0.34% of the stock is owned by company insiders.

Institutional Investors Weigh In On Colgate-Palmolive

A number of institutional investors have recently added to or reduced their stakes in the stock. Stonehage Fleming Financial Services Holdings Ltd increased its holdings in shares of Colgate-Palmolive by 57.1% in the fourth quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock valued at $30,594,000 after purchasing an additional 139,429 shares during the period. D L Carlson Investment Group Inc. acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $3,269,000. Diversify Advisory Services LLC purchased a new position in Colgate-Palmolive in the 1st quarter valued at about $911,000. TD Asset Management Inc boosted its holdings in Colgate-Palmolive by 2.4% in the 1st quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock worth $103,969,000 after buying an additional 26,987 shares during the last quarter. Finally, Empowered Funds LLC increased its stake in Colgate-Palmolive by 277.3% during the 1st quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock worth $2,979,000 after buying an additional 24,314 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 2.1 %

CL stock opened at $100.61 on Friday. The business’s fifty day moving average price is $103.61 and its two-hundred day moving average price is $96.94. The stock has a market capitalization of $82.54 billion, a price-to-earnings ratio of 31.84, a PEG ratio of 3.62 and a beta of 0.40. Colgate-Palmolive has a fifty-two week low of $68.44 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The company had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm’s quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.77 earnings per share. On average, equities analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 1.99%. Colgate-Palmolive’s payout ratio is 63.29%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.